Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-13 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-19 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ITRM | Iterum Therapeutics | 1.51 | 0.15 | 11.03% | 230.3M |
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Xeris Pharmaceuticals (NASDAQ:XERS), Jaguar Health (NASDAQ:JAGX) and Tricida (NASDAQ:TCDA).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by SVB Leerink on 2020-10-01. The analyst firm set a price target for 1.50 expecting ITRM to fall to within 12 months (a possible -0.66% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.51 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Iterum Therapeutics.
There is no upcoming split for Iterum Therapeutics.